China Medical rises on new drug application of acute ischemic stroke treatment

China Medical System Holdings

12/12/2025 04:52

** China Medical System Holdings 0867.HK rises 3.8% to HK$13.36; set for biggest one-day pct gain since December 1

** Chinese medicines producer says New Drug Application (NDA) of its Class 1 Innovative Drug Y-3 for Injection for treatment of acute ischemic stroke accepted by China's National Medical Products Administration

** Adds phase III clinical study of product met primary efficacy endpoint, with patients achieving significant clinical benefits, overall favorable safety profile

** YTD, stock up 74.3%

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))